Our Technology

EXOVEC™ — ENGINEERING EXOSOMES FOR PRECISION GENETIC DELIVERY

ExoVec™ is a modular delivery platform built on three integrated components: the exosome, the therapeutic DNA cargo, and our proprietary loading proteins. Together, they form a system that is precise, scalable and designed to reach tissues that no other gene therapy vector can access.

1

Exosome, the body’s natural carrier of biological material

2

Large strand DNA cargo (up to 36 kb)

3

Proprietary exosome loading proteins (ELPs) that stabilize, protect, and deliver DNA cargo to the cell nucleus while resisting inflammation

Exosome with DNA payload 1 2 3

KEY FEATURES OF EXOVEC™

large DNA payload

ExoVec™ can carry genetic material up to 36 kb, which is several times more than conventional viral vectors.

Minimal Toxicity

Built from the body's own vesicles, ExoVec™ is designed to deliver its cargo with low-to-no toxicity and minimal immune response.

Superior Delivery

ExoVec™ penetrates deep into target tissues, evades immune detection, and can reach organs that other delivery systems cannot.

COMPETITIVE ADVANTAGES

Comparison of ExoVec™ with viral vectors and lipid nanoparticles (LNP)
FeatureExoVec™Viral vectorsLNP
DNA cargo capacity36 kb5–10 kb15 kb
Nuclear deliveryStrongModerate to strongPoor
Tissue penetrationStrongModeratePoor
SafetyDesigned for low immunogenicityLow (pre-existing immunity)Moderate (cellular toxicity)
Repeat dosingPotential (in validation)NoYes
Production costsLow / scalableHighModerate

Swipe horizontally to compare all platforms.

Proof of Concept Data

Superior delivery, including 3D mini-hearts

More data available upon request.

Transduction comparison in a 3D mini-heart

No transfection

Mini-heart model — No transfection
Fluorescence microscopy — No transfection

LNP

Mini-heart model — LNP
Fluorescence microscopy — LNP

Ad vector

Mini-heart model — Ad vector
Fluorescence microscopy — Ad vector

ExoVec™

Mini-heart model — ExoVec™
Fluorescence microscopy — ExoVec™
DAPI
Nuclei of the cells
cTnT
Cardiomyocytes vitality marker
GFP
Transduction
Vimentin
Endothelial cells
Side-by-side comparison of ExoVec™ with LNPs and AdV in a 3D mini-heart model (consisting of iPS-derived cardiomyocytes, fibroblasts and endothelial cells) demonstrates the superior ability of ExoVec™ to penetrate in the tissue and to express the GFP transgene in cardiomyocytes.